期刊文献+

酵母细胞壁的盐酸氯丙嗪微囊的制备和稳定性考察

Preparation of chlorpromazine hydrochloride microcapsules with yeast cell wall and evaluation on their stability
原文传递
导出
摘要 目的以酵母细胞壁为囊材,制备盐酸氯丙嗪微囊,并观察其稳定性。方法以载药量为评价指标,采用正交试验设计确定制备盐酸氯丙嗪微囊最佳处方和工艺,并对微囊含量的检测方法进行精密度、稳定性及准确性验证。光学显微镜观察微囊形态,考察其体外释放、高湿度和强光照射的稳定性。结果在40℃,盐酸氯丙嗪与酵母细胞壁质量比为1∶3,时间为6 h,微囊的平均载药量可达41.76%。改进的含量检测方法精密度、稳定性、准确性良好。光学显微镜下可见微囊囊壁完整,呈球形或椭球形,形态均一。盐酸氯丙嗪微囊500 min体外累积释放为94.89%。盐酸氯丙嗪微囊对湿度和光度稳定性显著增加。结论酵母细胞壁可作为囊材用于制备微囊,且能增加药物的稳定性。 Objective To prepare chlorpromazine hydrochloride microcapsules by using yeast cell wall and observe their stability.Methods The formula and procedure were optimized by orthogonal design,serving drug-loading rate as an index for evaluation.The method for determination of drug-loading was verified for precision and stability.The microcapsules were observed for morphology by optical microscopy,and evaluated for drug release in vitro as well as the drug stabilities to high humidity and highlight exposure.Results The optimal temperature,ratio of chlorpromazine hydrochloride to yeast cell wall and time for preparation of microcapsules were 40 ℃,1 ∶ 3 and 6 h respectively.The drug-loading rate of microcapsules prepared under the optimal condition was 41.76%.The modified method for determination of drug-load showed high precision,stability and accuracy.Optical microscopy showed that the microcapsules were in even sphere or oval shape,with intact walls.A portion of 94.89% of total drug in the microcapsules were released in vitro within 500 min.The drug stability in microcapsules to humidity and light increased.Conclusion Yeast cell wall may be used as a material for preparation of microcapsule and may increase the drug stability.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第11期1550-1553,共4页 Chinese Journal of Biologicals
关键词 盐酸氯丙嗪 酵母细胞壁 微囊化 稳定性 Chlorpromazine hydrochloride Yeast cell wall Microcapsulation Stability
  • 相关文献

参考文献7

  • 1Krishnan PN,Saraswathi R,Dilip C,Ramarao N.Formulation and evaluation of acyclovir microcapsules using bakers yeast[J].Asian Pacific Journal of Tropical Medicine,2010,3(6):454-457. 被引量:1
  • 2Fieber W, Hafner V, Normand V. Oil droplet size determination in complex favor delivery systems by diffusion NMR spectroscopy [J]. J Colloid Interface Sei, 2011, 356 (2): 422-428.
  • 3Kasai T, Eguehi T, Ishiwaki N, et al. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive I. AYC as a novel coating material [J]. Int J Pharm, 2000, 204( 1-2): 53-59.
  • 4Dardelle G, Normand V, Steenhoudt M, et ol. Flavour-encapsula- tion and flavour-rolease performances of a commercial yeast-based delivery system [J]. Food Hydroeolloids, 2007, 21 (5-6): 953- 960.
  • 5Shi GR, Rao LQ, Yu HZ, et al. Yeast-cell-based microencapsula- fion of ehlorogenie acid as a water-soluble antioxidant [J]. J Food Engi, 2007, 80 (4): 1060-1067.
  • 6Shi GR, Rao LQ, Yu HZ, et al. Stabilization and encapsulation of photosensitive resveratrol within yeast cell [J]. Int J Phann, 2008, 349( 1-2): 83-93.
  • 7Yuasa H, Kaneshige J, Ozeki T, et al. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. II: effects of curing on the medicine release from AYC-coated tablets [J]. Int J Pharma, 2000, 209(1-2): 69-77.

二级参考文献15

  • 1Law S L,Huang K J,Chiang C H.Acyclovir-containing liposomes for potential ocular delivery corneal penetration and absorption. Journal of Controlled Release . 2000
  • 2M. Fresta,G. Fontana,C. Bucolo.Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. Journal of Pharmacological Sciences . 2001
  • 3N.Coceani,I.Colimbo,M.Grassi.Acyclovir permeation through rat skin:mathematical modeling and in vitro experiments. International Journal of Pharmaceutics . 2003
  • 4Zhang JH,Zhu JB,Chen XJ, et al.Pharmacokinetics and bioavailability of sustained release and conventional formulation of acyclovir. European Journal of Drug Metabolism and Pharmacokinetics . 2001
  • 5Trottet,L,Owen,H,Holme,P.Are all aciclovir cream formulations bioequivalent?. International Journal of Pharmaceutics . 2005
  • 6Tu J,Wang L,Yang J, et al.Formulation and pharmacokinetic studies of acyclovir controlled-release capsules. Drug Development and Industrial Pharmacy . 2001
  • 7GLADYS E G,GORDON L A.Stability of valacyclovir:implications for its oral bioavailability. International Journal of Pharmaceutics . 2006
  • 8Z. Pavelic,N. Skalko-Basnet,J. Filipovic-Grcic, et al.Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. Journal of Controlled Release . 2005
  • 9JRP Bishop,G Nelson,J Lamb.Microencapsulation in yeast cells. Journal of Microencapsulation . 1998
  • 10Genta I,Conti B,Perugini P,et al.Bioadhesive microspheres for ophthalmic administration of acyclovir. Journal of Pharmacokinetics and Pharmacodynamics . 1997

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部